Browse > Article
http://dx.doi.org/10.5012/bkcs.2011.32.2.576

Anticonvulsant Activity of a Combined Pharmacophore of Pyrazolo-pyridines with Lesser Toxicity in Mice  

Siddiqui, Nadeem (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University)
Ahsan, Waquar (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University)
Alam, M Shamsher (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University)
Ali, Ruhi (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University)
Srivastava, Kamna (Center for Biomedical Research, University of Delhi)
Ahmed, Sharique (Department of Biochemistry, Faculty of Medicine, 7th October University)
Publication Information
Abstract
Various 2-amino-6-[3-(substituted phenyl)-5-phenyl-4,5-dihydropyrazol-1-yl]-4-(substituted phenyl)nicotinonitriles (3a-t) were designed and synthesized by clubbing two active anticonvulsant pharmacophores pyrazole and pyridine. All the synthesized compounds possessed the pharmacophoric elements essential for good anticonvulsant activity. The anticonvulsant screening was performed by maximal electroshock seizure (MES) and subcutaneous pentylenetetrazole (scPTZ) tests. Two compounds 3i and 3s showed significant anticonvulsant activity in both the screens with $ED_{50}$ values 17.5 mg/kg and 22.6 mg/kg respectively in MES screen and 154.1 mg/kg and 242.6 mg/kg respectively in scPTZ screen. They were also found to have no acute toxic effects in mice when tested at elevated doses.
Keywords
Pyrazoles; Pyridines; Nicotinonitriles; Anticonvulsants; Neurotoxicity;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Bin, H.; Crider, A. M.; Stables, J. P. Eur. J. Med. Chem. 2001, 36, 265-286.   DOI   ScienceOn
2 Kaminski, K.; Obniska, J.; Zagorska, A.; Maciag, D. Arch. Pharm. 2006, 339, 255-261.   DOI   ScienceOn
3 Siddiqui, N.; Alam, P.; Ahsan, W. Arch. Pharm. 2009, 342, 173-181.   DOI   ScienceOn
4 Mamolo, M. G.; Zampieri, D.; Falagiani, V.; Vio, L.; Banfi, E. IL Farmaco 2001, 56, 593-599.   DOI   ScienceOn
5 Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.; Swinyard, E. A. Epilepsia 1978, 19, 409-428.   DOI   ScienceOn
6 Clark, C. R.; Wells, M. J. M.; Sansom, R. T.; Norris, G. N.; Dockens, R. C.; Ravis, W. R. J. Med. Chem. 1984, 27, 779-782.   DOI
7 Litchfield, J. T.; Wilcoxon, F. J. Pharmacol. Exp. Ther. 1949, 96, 99-113.
8 Dunham, N. W.; Miya, T. A. J. Am. Pharm. Assoc. Sci. 1957, 46, 208-209.
9 Reitman, S.; Frankel, S. A. Am. J. Clin. Pathol. 1957, 28, 56-63.
10 King, E. J.; Armstrong, A. R. Can. Med. Assoc. J. 1934, 31, 376-381.
11 Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. J. Comput. Chem. 1983, 4, 187-217.   DOI
12 Eddington, N. D.; Cox, D. S.; Roberts, R. R.; Butcher, R. J.; Edafiogho, I. O.; Stables, J. P.; Cooke, N.; Goodwin, A. M.; Smith, C. A.; Scott, K. R. Eur. J. Med. Chem. 2002, 37, 635-648.   DOI   ScienceOn
13 Lukevits, E. Chem. Heter. Comp. 1995, 31, 639-650.   DOI
14 Ozdemir, Z.; Kandilci, H. B.; Gümüşel, B.; Caliş, U.; Bilgin, A. A. Eur. J. Med. Chem. 2007, 42, 373-379.   DOI   ScienceOn
15 Ozdemir, Z.; Burak, K. H.; Gumusel, B.; Calis, U.; Altan, B. A. Arch. Pharm. 2008, 341, 701-707.   DOI   ScienceOn
16 Abdel-Aziz, M.; El-Din, A. G.; Hassan, A. A. Eur. J. Med. Chem. 2001, 44, 3480-3487.
17 Narendar, P.; Parthiban, J.; Anbalagan, N.; Gunasekaran, V.; Leonard, T. J. Biol. Pharm. Bull. 2003, 26, 182-187.   DOI   ScienceOn